Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Finance Herald.
Press releases published on April 4, 2025

AYR Wellness Announces Changes to Management
MIAMI, April 04, 2025 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (“AYR” or the “Company”) (CSE: AYR.A, OTCQX: AYRWF) a leading vertically integrated U.S. multi-state cannabis operator, announced that, effective today, Steven M. Cohen has stepped down as the …

A-Mark Precious Metals Announces Quarterly Cash Dividend and the Closing of Its Acquisition of AMS Holding, LLC
EL SEGUNDO, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- A-Mark Precious Metals, Inc. (NASDAQ: AMRK) (A-Mark), a leading fully integrated precious metals platform, today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 …

Board Member Robert Griffin to Retire; William Johnson to Become Chairman of the Board
NEW ALBANY, Ohio, April 04, 2025 (GLOBE NEWSWIRE) -- Commercial Vehicle Group, Inc. (the “Company” or “CVG”) announced the retirement of Robert C. Griffin, from the Board of Directors of the Company, effective May 15, 2025, without standing for re-election …

Tabhi acquires Mondee out of Chapter 11 Restructuring and Boosts Liquidity and Capital Structure
AUSTIN, Texas, April 04, 2025 (GLOBE NEWSWIRE) -- Mondee Holdings, Inc. announces its acquisition by Tabhi, and exit from Chapter 11 restructuring. Tabhi acquired substantially all the assets of Mondee Holdings, Inc. and strengthened its balance sheet by …

EluPro™ Named as 2025 Edison Award Winner
Innovative Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Pacemakers and Neurostimulators Earns Bronze in Post-Surgical Recovery Solutions Category SILVER SPRING, Md., April 04, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia …

Palvella Therapeutics to Present at the Jones Healthcare and Technology Innovation Conference
WAYNE, Pa., April 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare …

OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program
MIAMI, April 04, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that its Board of Directors has authorized an increase of $100 million to the Company’s existing common stock repurchase program, bringing the aggregate capacity of …

Live Markets Announces LMGX Token, Setting the Stage for a Landmark Security Token Offering in 2027
SOFIA, Bulgaria, April 04, 2025 (GLOBE NEWSWIRE) -- Live Markets has officially announced the launch of LMGX, a blockchain-powered digital asset designed to drive financial and trading innovation. Operating under the esteemed LM Group umbrella, Live …

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, April 04, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on …

Labrador Gold Provides Corporate Update
TORONTO, April 04, 2025 (GLOBE NEWSWIRE) -- Labrador Gold Corp. (TSX.V: LAB | OTCQB: NKOSF | FNR: 2N6) (“LabGold” or the “Company”) is pleased to provide an update on the Company’s strategic progress, including its ongoing efforts to secure a significant …

FORAFRIC GLOBAL Announces Leadership Transition: New Chairman of the Board Appointed
CASABLANCA, MOROCCO, April 04, 2025 (GLOBE NEWSWIRE) -- Forafric Global (Nasdaq: AFRI, or the « Company »), a leading vertically integrated agribusiness serving Africa, today announced that Khalid Assari, the CEO of the Company, has been appointed as …

Hundreds of Texas Businesses to Testify Against SB3 and HB28 as Texas Hemp Business Council Urges House Lawmakers to Reject Industry-Killing Legislation
AUSTIN, Texas, April 04, 2025 (GLOBE NEWSWIRE) -- Hundreds of local businesses, farmers and industry advocates will gather at the Texas Capitol on Monday, April 7 to testify against Senate Bill 3 and House Bill 28, sending a clear message that this …

Rogers Communications Inc. Announces Consent Solicitations for Senior Notes to Facilitate Subsidiary Equity Investment
TORONTO, April 04, 2025 (GLOBE NEWSWIRE) -- Rogers Communications Inc. (TSX: RCI.A and RCI.B; NYSE: RCI) (“Rogers”) today announced that it has commenced consent solicitations to amend the indentures governing certain of its outstanding US dollar- …

Rogers concludes definitive agreement for CDN$7 billion equity investment
Proceeds will be used to repay debt Expects debt leverage ratio to be reduced by 0.7x following the close of the transaction Rogers will maintain full operational control of its wireless network TORONTO, April 04, 2025 (GLOBE NEWSWIRE) -- Rogers …

IREN March 2025 Monthly Update
SYDNEY, April 04, 2025 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) (together with its subsidiaries, “IREN” or “the Company”), today published its monthly update for March 2025. March Highlights Operating data center capacity increased to 660MW Bitcoin …

Arvinas Presents First-in-Human Data for Investigational Oral PROTAC ARV-102 Demonstrating Blood-Brain Barrier Penetration, and Central and Peripheral LRRK2 Degradation
– Data demonstrate that ARV-102 was well tolerated, orally bioavailable, and brain-penetrant; ARV-102 achieved central and peripheral LRRK2 reduction indicating substantial LRRK2 protein degradation in healthy volunteers – – Findings support continued …

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
RESEARCH TRIANGLE PARK, N.C., April 04, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted 10 newly-hired employees restricted stock units (RSUs) …

AccuStem Sciences to Offer its MSC Blood Test to Lung Cancer Screening Programs in the United States
LONDON and PHOENIX, April 04, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, announces plans to launch its microRNA Signature …

NextCure to Present at 24th Annual Needham Virtual Healthcare Conference
BELTSVILLE, Md., April 04, 2025 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer, today announced that it …

Nutriband Signs Partnership Agreement with Charlotte FC
ORLANDO, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (the “Company”)(NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced that it has signed an Associate Partnership agreement with Charlotte FC. The …